Brian Weinstein


William Blair Comments on Sequenom, Inc. (SQNM) Following Supreme Court Patent Ruling

William Blair analyst Brian Weinstein chimed in today on Sequenom, Inc. (NASDAQ:SQNM), following the news that the Supreme Court rejected Sequenom’s appeal of a prior ruling invalidating …

William Blair Shines Light on Sequenom, Inc. (SQNM) CEO Resignation

William Blair analyst Brian Weinstein weighed in with his views on Sequenom, Inc. (NASDAQ:SQNM), after the company announced that Chief Scientific and Strategy Officer Dirk van den …

William Blair Reiterates Outperform on EXACT Sciences Corporation Following Investor Day

In a research report issued on Friday, William Blair analyst Brian Weinstein offered some insights EXACT Sciences Corporation (NASDAQ:EXAS) following the company’s first investor day held yesterday. …

William Blair Comments On Exact Sciences Following Public Offering

William Blair analyst Brian Weinstein maintained an Outperform rating on Exact Sciences (NASDAQ:EXAS), as the company announced a bought deal for 4 million shares of …

William Blair Comments On Sequenom In Light Of IP Settlement With Illumina

William Blair analyst Brian Weinstein reiterated an Outperfom rating on Sequenom (NASDAQ:SQNM), following the news that Sequenom and Illumina reached an agreement to settle all pending IP claims …

William Blair Maintains Outperform On Exact Sciences Following UnitedHealth Noncoverage Decision

William Blair analyst Brian Weinstein maintained an Outperform rating on Exact Sciences (NASDAQ:EXAS), following yesterday’s news that UnitedHealth (NYSE:UNH) issued an updated medical policy on …

William Blair Reiterates Outperform On Exact Sciences Following Issuance Of Final CMS Reimbursement Decision

In a research report released Wednesday, William Blair analyst Brian Weinstein reiterated an Outperform rating on Exact Sciences (NASDAQ:EXAS), following the news that the Centers …

William Blair Maintains Outperform On Cepheid Shares

In a research report issued today, William Blair analyst Brian Weinstein maintained an Outperform rating on Cepheid (NASDAQ:CPHD). No price target was provided.

William Blair Maintains Outperform On Exact Sciences As It Received $502 Reimbursement For Cologuard

In a research report sent to investors today, William Blair analyst Brian Weinstein reiterated an Outperform rating on Exact Sciences (NASDAQ:EXAS), following yesterday’s news that …

William Blair Reiterates Outperform On Becton Dickinson Following Investor Meetings With Management

In a research report issued today, William Blair analyst Brian Weinstein reiterated an Outperform rating on Becton, Dickinson and Co (NYSE:BDX). No price …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts